In recent years,China's policy of encouraging innovation has begun to yield significant results in promoting drug research,development,and international expansion.Amid the current economic slowdown and various internal and external pressures,the internationalization of China's innovative drugs helps to expand market reach and facilitate the"dual circulation"strategy,thereby benefiting domestic research and development.Continued policy support and enhancement in this area are crucial.Japan's pharmaceutical industry faced similar challenges in the 20th century,including population aging and economic stagnation.The implementation of policies encouraging innovation and internationalization enabled some companies to successfully enter global markets.China can draw valuable lessons from these successes.This paper provides an overview of the current status of China's innovative drugs going global,analyzes Japan's successful experience,and offers policy recommendations.It is recommended that pharmaceutical policies continue to firmly promote innovation,encourage drug companies to focus on clinical value-driven research from the outset,support capable companies in expanding internationally,and provide assistance in terms of policies and funding to globally competitive enterprises.
关键词
人口老龄化/创新药出海/鼓励创新/全球化/产业政策
Key words
population aging/innovative drugs internationalization/encouraging innovation/globalization/industrial policy
维普
万方数据